• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重的医院管理。

Hospital management of acute exacerbations of chronic obstructive pulmonary disease.

作者信息

Chow Leonard, Parulekar Amit D, Hanania Nicola A

机构信息

Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, Texas.

出版信息

J Hosp Med. 2015 May;10(5):328-39. doi: 10.1002/jhm.2334. Epub 2015 Mar 27.

DOI:10.1002/jhm.2334
PMID:25820201
Abstract

The course of chronic obstructive pulmonary disease (COPD) is often complicated by episodes of acute worsening of respiratory symptoms, which may lead to escalation of therapy and occasionally emergency department visits and hospitalization. Acute exacerbations of COPD (AECOPD) have a negative impact on quality of life and hasten the decline of lung function. They also significantly contribute to the direct and indirect healthcare costs of this disease. Severe exacerbations (those leading to hospital admission) have been associated with significant poor outcomes including an increased risk of readmissions and mortality. COPD is currently the fourth leading cause of hospital readmission in the United States. In this review, we will provide a broad overview on the etiology, assessment, management, discharge planning, and follow-up care of patients hospitalized with AECOPD.

摘要

慢性阻塞性肺疾病(COPD)的病程常因呼吸道症状急性加重发作而复杂化,这可能导致治疗升级,偶尔还会导致急诊就诊和住院。慢性阻塞性肺疾病急性加重(AECOPD)对生活质量有负面影响,并加速肺功能下降。它们还显著增加了这种疾病的直接和间接医疗费用。严重加重(导致住院)与显著不良结局相关,包括再入院风险和死亡率增加。COPD目前是美国医院再入院的第四大主要原因。在本综述中,我们将对因AECOPD住院患者的病因、评估、管理、出院计划和随访护理进行广泛概述。

相似文献

1
Hospital management of acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的医院管理。
J Hosp Med. 2015 May;10(5):328-39. doi: 10.1002/jhm.2334. Epub 2015 Mar 27.
2
Acute exacerbations of chronic obstructive pulmonary disease in the emergency department.急诊科慢性阻塞性肺疾病急性加重
Emerg Med Clin North Am. 2012 May;30(2):223-47, vii. doi: 10.1016/j.emc.2011.10.005.
3
[Exacerbations of COPD--new aspects in pathogenesis and therapy].[慢性阻塞性肺疾病急性加重——发病机制与治疗的新进展]
Praxis (Bern 1994). 2004 Apr 28;93(18):763-8. doi: 10.1024/0369-8394.93.18.763.
4
Predicting outcomes following hospitalization for acute exacerbations of COPD.预测 COPD 急性加重住院后的结局。
QJM. 2010 Nov;103(11):817-29. doi: 10.1093/qjmed/hcq126. Epub 2010 Jul 26.
5
[Management of acute exacerbation of chronic obstructive pulmonary disease (COPD)].[慢性阻塞性肺疾病(COPD)急性加重的管理]
Dtsch Med Wochenschr. 2003 Aug 15;128(33):1721-7. doi: 10.1055/s-2003-41341.
6
Assessment and management of chronic obstructive pulmonary disease in the emergency department and beyond.急诊科及其他科室的慢性阻塞性肺疾病评估与管理。
Expert Rev Respir Med. 2011 Aug;5(4):549-59. doi: 10.1586/ers.11.43.
7
Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.慢性阻塞性肺疾病急性加重:危重症患者的诊断、管理与预防
Pharmacotherapy. 2015 Jun;35(6):631-48. doi: 10.1002/phar.1599. Epub 2015 Jun 1.
8
The quality of medical care during an acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的医疗质量。
Rev Med Chir Soc Med Nat Iasi. 2013 Oct-Dec;117(4):870-4.
9
Exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重
Med J Malaysia. 2009 Sep;64(3):250-5; quiz 256.
10
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重
Proc Am Thorac Soc. 2007 Oct 1;4(7):554-64. doi: 10.1513/pats.200701-003FM.

引用本文的文献

1
Healthcare utilization after a first hospitalization for COPD: a new approach of State Sequence Analysis based on the '6W' multidimensional model of care trajectories.首次因 COPD 住院后的医疗保健利用:基于“6W”多维护理轨迹模型的状态序列分析新方法。
BMC Health Serv Res. 2020 Mar 6;20(1):177. doi: 10.1186/s12913-020-5030-0.
2
Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis.雾化布地奈德作为慢性阻塞性肺疾病急性加重初始治疗的临床结局:一项事后分析
Int J Chron Obstruct Pulmon Dis. 2019 Nov 29;14:2725-2731. doi: 10.2147/COPD.S196615. eCollection 2019.
3
Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.
降低慢性阻塞性肺疾病的住院再入院率。美国胸科学会官方专题研讨会报告。
Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.
4
To Investigate the Effects of Air Pollution (PM10 and SO) on the Respiratory Diseases Asthma and Chronic Obstructive Pulmonary Disease.调查空气污染(PM10和SO)对呼吸系统疾病哮喘和慢性阻塞性肺疾病的影响。
Turk Thorac J. 2017 Apr;18(2):33-39. doi: 10.5152/TurkThoracJ.2017.16016. Epub 2017 May 15.
5
Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism.用于检测伴或不伴肺栓塞的慢性阻塞性肺疾病急性加重的嗜酸性粒细胞生物标志物。
Exp Ther Med. 2017 Oct;14(4):3198-3206. doi: 10.3892/etm.2017.4876. Epub 2017 Aug 2.
6
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol.使用雾化阿福特罗或雾化福莫特罗治疗的慢性阻塞性肺疾病住院患者的卫生资源利用情况。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 20;12:1793-1801. doi: 10.2147/COPD.S134145. eCollection 2017.